However, several evidence-based trials have shown that topiramate and botulinum toxin are efficient in the treatment of chronic headaches, and expert opinion suggests that conventional prophylactic therapy used for migraine and tension type headache may be recommended [ 24– 27].
US-based trials have shown that Multidimensional Family Therapy (MDFT) not only reduces substance abuse among adolescents, but also decreases mental and behavioural disorder symptoms, most notably externalising symptoms.
The true prevalence of uterine sarcoma in presumed fibroids is not known, and meta-analyses based on retrospective trials have shown a wide range of prevalence (0.014 0.45%).
These traditional nutritionally oriented (or non-pharmaconutrition based) GLN supplementation trials have shown a consistent reduction of mortality and benefit on other outcomes as suggested by the 2009 update of the Canadian Critical Care Nutrition Guidelines [ 47].
Estimated savings are based on 10%and15%5% weight loss, as recent clinical trials have shown these results to be attainable based on Intent-to Treat (ITT) and Completers analyses, respectively.
Based on these results, several clinical trials have shown first encouraging effects in patients with Alzheimer's or Parkinson' disease.
Evidence based research substantiated by reliable field trials have shown improved performance in sheep.
Population based intervention studies and randomised controlled clinical trials have shown that it is possible to achieve significant reductions in blood pressure with reduced salt intake in people with and without hypertension.
6 Several phase III randomised controlled trials have shown the benefit of adjuvant platinum based chemotherapy in patients with stages II-IIIA non-small cell lung cancer.
Several randomised controlled trials have shown the efficacy of adjuvant platinum based chemotherapy after resection among patients with stages II-IIIA non-small cell lung cancer.
2004 58 7):1030 1037. Introduction: Several clinical trials have shown beneficial effects of parenteral lipid emulsions based on n-3 polyunsaturated fatty acids (PUFAs) (derived from fish oil) in intensive care unit (ICU) patients receiving parenteral nutrition (PN).
